Nystatin Leadership Antibiotice is the world leader in producing Nystatin active pharmaceutical ingredient (API) with USP recognizing its Nystatin as the international reference standard for quality since 2017, presenting a strong differentiator for global partners seeking high-quality antifungal APIs.

Global Market Reach With presence in over 70 countries and a robust Romanian hospital supply of antiinfectives, there are multiple regional expansion opportunities for partnerships, co-development, or contract manufacturing with emphasis on infectious disease therapies.

Financing Backing Recent multi‑million euro/ dollar financing facilities from Banca Transilvania bolster capabilities for strategic production and innovation projects, offering potential for co‑funded initiatives, capacity expansion, and accelerated time‑to‑market with partners.

R&D Investment Plans to invest in a new R&D center focused on critical medicines indicate openness to collaborative development, licensing, and joint ventures to advance high‑need, high‑margin therapeutics and generic equivalents.

Quality Compliance EU‑GMP, COS, and FDA authorizations underpin credibility with global buyers and regulators, enabling sales opportunities for both generic and API partnerships in regions prioritizing stringent quality standards.